Description
Imatigliv 400mg tablet is an oral targeted cancer medication containing the active ingredient imatinib mesylate. It works as a tyrosine kinase inhibitor (TKI) by blocking abnormal proteins that signal cancer cells to multiply. It is primarily prescribed to treat blood and bone marrow cancers (such as Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia) and Gastrointestinal Stromal Tumors (GIST). [1, 2, 3]
Key Details & Administration
- Administration: Swallow the tablets whole. If you have difficulty swallowing, dissolve the 400mg tablet in approximately 200 ml of water or apple juice and drink it immediately

Reviews
There are no reviews yet.